Morgan Stanley Maintains Overweight on Colgate-Palmolive, Lowers Price Target to $95

Benzinga Newsdesk www.benzinga.com Negative 74.5%

Neg 74.5% Neu 0% Pos 0%

Morgan Stanley analyst Dara Mohsenian maintains Colgate-Palmolive (NYSE:CL) with a Overweight and lowers the price target from $100 to $95.